痰热清注射液对社区获得性肺炎临床疗效及血清PCT水平的影响

目的 探讨痰热清注射液对社区获得性肺炎临床疗效及血清降钙素原（PCT）水平的影响。方法 选择116例社区获得性肺炎患者为研究对象，依据随机数字表法分为试验组和对照组各58例。对照组采用抗感染、化痰、对症等常规治疗，试验组在此基础上联合痰热清注射液治疗，观察两组患者的体温、临床症状、PCT水平变化。结果 试验组总有效率为94.8%，对照组为81.0%，试验组总有效率明显高于对照组，差异有统计学意义（P<0.05）；治疗后两组血清PCT水平均降低（P<0.05），但试验组较对照组降低明显，差异有统计学意义（P<0.05）。结论 痰热清注射液能显著改善社区获得性肺炎患者临床症状，提高临床疗效，下调血清PCT浓度，且无明显不良反应发生。

Effect of Tanreqing Injection on Community-acquired Pneumonia Clinical Efficacy and PCT Level

Objective To investigate the change of serum procalcitonin (PCT) level and clinical efficacy of community-acquired pneumonia (CAP) with the application of Tanreqing Injection.Methods 116 patients with CAP were divided into experimental group (58 cases) and control group (58 cases) by random number table.The control group was treated with antibiotics,expectorant and general treatment,on this basis,the experimental group was treated with Tanreqing Injection.The temperature,clinical symptoms and serum procalcitonin level were observed of two group patients.Results The total effective rate in the experimental group was 94.8%,the control group with 81.0%,the effect of experimental group was superior to the control group,the difference was statistically significant (P<0.05).The level of procalcitonin of two group was decreased and the decrease degree of experimental group was better than the control group,the difference was statistically significant (P<0.05).Conclusion Tanreqing injection can obviously improve the clinical symptoms of CAP,improve the curative effect,reduce the level of procalcitonin,and with no significant adverse reactions.